NEW YORK — Shiseido is preparing to unleash Benefiance Wrinkle Lifting Concentrate, its latest product derived through a research venture involving the cosmetics company, Harvard Medical School and Massachusetts General Hospital. To launch in November, the antiage item could generate first-year U.S. retail sales of $3.5 million. For more, see story, “Shiseido Hopes for Benefiance Boon.”
This story first appeared in the August 8, 2003 issue of WWD. Subscribe Today.